Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycemia.
Roux-en-Y gastric bypass (RYGBP) is the most commonly performed type of bariatric surgery, which is used in the treatment of obesity and type 2 diabetes. Recent case reports and case series have described a rare complication of RYGBP, status post-gastric-bypass hyperinsulinemic hypoglycemia, which was mainly managed successfully with pancreatectomy. In this letter, we describe the first successful management of status post-gastric-bypass hyperinsulinemic hypoglycemia with diazoxide.
Spanakis
Elias
E
Laboratory of Molecular Genetics of Complex and Monogenic Disorders, Division of Endocrinology, Diabetes and Metabolism, H044, Department of Medicine and Cellular and Molecular Physiology and Public Health Sciences, Penn State Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA 17033, USA.
Gragnoli
Claudia
C
D000959:Antihypertensive Agents / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D015390:Gastric Bypass / Q000009:adverse effects*; D006801:Humans; D006946:Hyperinsulinism / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D007003:Hypoglycemia / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D008875:Middle Aged; D009765:Obesity / Q000150:complications / Q000601:surgery*
D000959:Antihypertensive Agents; D003981:Diazoxide